Skin autofluorescence as a tool for cardiovascular risk estimation in patients with rheumatoid arthritis

Eur J Intern Med. 2019 Aug:66:e7-e8. doi: 10.1016/j.ejim.2019.06.011. Epub 2019 Jun 26.

Authors

S H Bakker-Aling¹, J M van Woerkom², T P Zomer¹, H C J L Buscher³, T van Bemmel⁴

Affiliations

¹ Department of Internal Medicine, Gelre Hospital, Apeldoorn, the Netherlands.
² Department of Rheumatology, Gelre Hospital, Apeldoorn, the Netherlands.
³ Department of Surgery, Gelre Hospital, Apeldoorn, the Netherlands.
⁴ Department of Internal Medicine, Gelre Hospital, Apeldoorn, the Netherlands. Electronic address: [email protected].

PMID: 31253386
DOI: 10.1016/j.ejim.2019.06.011

No abstract available

Keywords: Advanced Glycation End; Cardiovascular disease; Disease activity; Rheumatoid arthritis; Skin autofluorescence.

Publication types

Letter

MeSH terms

Adult
Aged
Arthritis, Rheumatoid / complications*
Arthritis, Rheumatoid / metabolism
Cardiovascular Diseases / diagnosis*
Cardiovascular Diseases / epidemiology
Female
Glycation End Products, Advanced / metabolism*
Humans
Luminescent Measurements / methods
Male
Middle Aged
Netherlands
Predictive Value of Tests
Prospective Studies
Risk Assessment / methods*
Risk Factors
Skin / diagnostic imaging
Skin / metabolism*

Substances

Glycation End Products, Advanced